Brian Benson, DPM
Foot & Ankle Surgery · Leesville, LANPI 1104350883
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $220,726 of the $278,387 with a category attached, or 79.3%. 33 manufacturers reported payments, led by Bone Support Inc. at 35.7% of the total. 2025 is the largest year on record at $96,957, more than ten times the $498 reported in 2020. Among foot & ankle surgery clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $924.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bone Support Inc.$99K
- Medshape, Inc.$48K
- Fusion Orthopedics USA, LLC$38K
- New Standard Device, LLC Dba Metalogix$27K
- Linvatec Corporation$22K
- Nvision Biomedical Technologies, Inc.$10K
- plus $34K from 27 others
Across 5 payments — averaging $5462.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acera Surgical, Inc.$18K
- Innovation Technologies Inc$9K
What the payments were for
- Royalty or licence$1,2260%
- Consulting fees$220,72679%
- Speaking & faculty fees$5,2082%
- Travel & lodging$39,84314%
- Food & beverage$6,8792%
- Education$3,0171%
- Other$1,4901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bone Support Inc. | 61 | $99,481 |
| Medshape, Inc. | 65 | $47,995 |
| Fusion Orthopedics USA, LLC | 21 | $37,638 |
| New Standard Device, LLC Dba Metalogix | 3 | $26,936 |
| Linvatec Corporation | 26 | $21,950 |
| Nvision Biomedical Technologies, Inc. | 8 | $9,970 |
| Acera Surgical, Inc. | 12 | $6,203 |
| F&a Foundation, LLC | 1 | $4,769 |
| Alafair Biosciences, Inc. | 3 | $4,702 |
| Trilliant Surgical LLC. | 16 | $4,057 |
| Arthrex | 13 | $3,365 |
| Orthofix Medical, Inc. | 22 | $2,016 |
| Ortho Solutions Inc | 7 | $1,503 |
| Paragon 28, Inc. | 4 | $1,352 |
| Winter Innovations, Inc. | 3 | $1,238 |
| Voom Medical Devices, Inc. | 4 | $1,222 |
| Intelivation Technologies, LLC | 1 | $1,000 |
| In2bones USA, LLC | 2 | $623 |
| Fuse Medical, Inc. | 1 | $500 |
| Team 1, LLC | 1 | $482 |
| Flower Orthopedics Coporation | 5 | $282 |
| Zimmer Biomet | 3 | $266 |
| Encore Medical, LP | 1 | $233 |
| Carbofix Orthopedics Inc | 1 | $122 |
| Stryker | 2 | $92 |
| Acumed LLC | 2 | $88 |
| AbbVie | 4 | $63 |
| Exactech, Inc. | 1 | $62 |
| Solventum Corporation | 2 | $47 |
| Kerecis Limited | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Organogenesis Inc. | 1 | $27 |
| Bioventus LLC | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$99,252
- CERAMENT G$91,752
- DynaNail Helix, Washer, 15 mm$36,850
- DynaClip Bone Fixation System, Quattro, 22mm x 20mm x 20mm$22,974
- BioBrace 23mm$17,475
- DynaNail$15,064
- HERCULES SUTURE ANCHOR SYSTEM$12,429
- Restrata Wound Matrix$6,086
- Foot/ankle products$5,720
- VersaWrap$4,621
- Foot and Ankle$4,250
- CARTIMAX$4,172
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$2,608
- TrueLok$1,328
- Product Portfolio$1,128
- Arsenal Sinus Support Plate$1,122
- REVCON$1,097
- NeoSpan$627
- Metalogix$538
- Orbitum Staple System$500
How this compares
$278,387 in reported general payments places this provider in the 95th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 35 | $665 |
| Ciclopirox | 16 | $305 |
| Terbinafine Hcl | 31 | $235 |
| Clotrimazole | 25 | $219 |
| Gabapentin | 17 | $208 |
| Doxycycline Hyclate | 16 | $181 |
| Meloxicam | 39 | $117 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $76 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Leesville
- Jacob BlakemanLeesville$11K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
- Leon WatkinsMetairie$18K
- Phuoc BuiMinden$15K
- Henrique HilarioShreveport$14K
- Beau WillisMetairie$13K
- Nimish ChokshiMetairie$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.